Medtronic plc (MDT)

84.22
0.51 0.60
NYSE
Prev Close 84.73
Open 84.54
Day Low/High 82.77 / 84.64
52 Wk Low/High 76.41 / 100.15
Volume 6.80M
Exchange NYSE
Shares Outstanding 1341.15B
Market Cap 113.64B
Div & Yield N.A. (N.A)
Blowout Earnings From 'Boring' Companies Makes It Hard to Be Bearish

Blowout Earnings From 'Boring' Companies Makes It Hard to Be Bearish

Many investors don't seem too impressed by the constantly better-than-expected earnings results from companies this quarter. But those results make it hard to be bearish, Jim Cramer says.

Dexcom, Lilly Team Up on Diabetes System

Companies aim to improve disease management.

Video: Jim Cramer Says Medtronic Is Putting Up 'Unbelievable' Numbers

Video: Jim Cramer Says Medtronic Is Putting Up 'Unbelievable' Numbers

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer was pleased with Medtronic's latest quarterly earnings.

Don't Blame the Earnings: Cramer's 'Mad Money' Recap (Friday 11/17/17)

Don't Blame the Earnings: Cramer's 'Mad Money' Recap (Friday 11/17/17)

This pullback is a textbook example of why you can't take your cue only from the action, says Jim Cramer.

12 Stocks This Top Research Firm Wants You to Buy Now

12 Stocks This Top Research Firm Wants You to Buy Now

These are the 12 best investment selections from Fundstrat that may provide investors with 'timely' long-term potential.

Medtronic Quantifies Short-Term Impact of Hurricane Maria, Analysts Lower PT

Medtronic Quantifies Short-Term Impact of Hurricane Maria, Analysts Lower PT

Leerink analysts lowered their price target on Medtronic's stock and reiterated their market perform rating after the medical device maker on Oct. 6 gave an estimate of the financial impact from Hurricane Maria on its fiscal 2018 second quarter. Medtronic said it was too soon to determine the hurricane's impact, if any, beyond the quarter.

Johnson & Johnson Calls It Quits on Insulin Pumps Business

Johnson & Johnson Calls It Quits on Insulin Pumps Business

Increasing competition has made selling insulin pumps unsustainable for J&J.

Medtronic Looks Vulnerable to a Bigger Decline

Medtronic Looks Vulnerable to a Bigger Decline

The stock has been correcting to the downside since July.

FDA Approves Abbott Heart Device, Stock Rises

FDA Approves Abbott Heart Device, Stock Rises

The HeartMate 3 received regulatory approval.

Measure the Meaning of This Rally: Cramer's 'Mad Money' Recap (Tues 8/22/17)

Measure the Meaning of This Rally: Cramer's 'Mad Money' Recap (Tues 8/22/17)

Jim Cramer says commodities, China's strength, global market gains and more all point to keeping this rally alive.

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

America's biggest hedge funds are worth over $6 trillion combined, and here are the most common stocks they're selling.

Cramer: This Rally Isn't Without Meaning

Cramer: This Rally Isn't Without Meaning

Accentuate the positives, ignore the negatives.

Cramer: This Rally Is Just the Reverse of the Selloff

Cramer: This Rally Is Just the Reverse of the Selloff

It is tech that really is screaming to be noticed.

Afghanistan and Jackson Hole - 5 Things You Must Know Before the Market Opens

Afghanistan and Jackson Hole - 5 Things You Must Know Before the Market Opens

U.S. stock futures rise Tuesday, and shares in Europe and Asia move higher.

Novartis AG, Sirius XM Radio, Coupa Software: 'Mad Money' Lightning Round

Novartis AG, Sirius XM Radio, Coupa Software: 'Mad Money' Lightning Round

Jim Cramer is bullish on Novartis AG, Sirius XM Radio, Coupa Software and Juno Therapeutics.

August's Inexplicable Selloffs Are Here: Cramer's 'Mad Money' Recap (8/17/17)

August's Inexplicable Selloffs Are Here: Cramer's 'Mad Money' Recap (8/17/17)

Jim Cramer says the calendar and the momentum holders are coalescing to produce selling. Here's what investors should do about it.

EY's Greene Sees More Med Tech, CRO Deals Ahead

EY's Greene Sees More Med Tech, CRO Deals Ahead

Consolidation, improving equity prices and sufficient firepower for deals continue to fuel med tech M&A, according to EY's Jeff Greene.

These Stocks Are Ready to Reverse Course

These Stocks Are Ready to Reverse Course

Identifying this week's bullish and bearish reversal patterns.

Transports Finally Get Some Attention

ETF may be in for a bounce.

Cardinal Health Selling China Business Worth Up to $1.5 Billion

Cardinal Health Selling China Business Worth Up to $1.5 Billion

State-backed Chinese pharmaceutical companies have shown interest.

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of Medtronic Plc And Advises Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of Medtronic Plc And Advises Investors With Losses To Contact The Firm

Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Medtronic plc ("Medtronic" or the "Company") (NYSE: MDT) concerning possible violations of federal securities laws.

INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Medtronic Plc

INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Medtronic Plc

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medtronic plc ("Medtronic" or the "Company") (NYSE: MDT).

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Medtronic Plc

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Medtronic Plc

Levi & Korsinsky announces it has commenced an investigation of Medtronic plc ("Medtronic" or the "Company") (NYSE:MDT) concerning possible violations of federal securities laws.

Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Medtronic Plc Investors

Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Medtronic Plc Investors

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Medtronic plc ("Medtronic" or the "Company") (NYSE: MDT) investors concerning the Company and its officers' possible violations of...

Medtronic CFO Expects Q1 Sales at Low End of Guidance

Medtronic CFO Expects Q1 Sales at Low End of Guidance

Medtronic is still working to fill back orders.

As Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals

As Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals

The Trump administration's creep towards scrapping certain tax regulations could revive inversion deals that have allowed U.S. companies to avoid billions of dollars in taxes.

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra announced in February its intent to acquire Codman Neurosurgery from Johnson & Johnson.

TheStreet Quant Rating: B (Buy)